Mena Soliman

535 total citations
32 papers, 355 citations indexed

About

Mena Soliman is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mena Soliman has authored 32 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Physiology, 17 papers in Immunology and Allergy and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mena Soliman's work include Asthma and respiratory diseases (26 papers), Allergic Rhinitis and Sensitization (17 papers) and Respiratory and Cough-Related Research (6 papers). Mena Soliman is often cited by papers focused on Asthma and respiratory diseases (26 papers), Allergic Rhinitis and Sensitization (17 papers) and Respiratory and Cough-Related Research (6 papers). Mena Soliman collaborates with scholars based in Canada, United States and France. Mena Soliman's co-authors include Anne K. Ellis, Andrew Cave, Andrew McIvor, Claudia Cabrera, Lisa M. Steacy, M. Dunnett, Roger C. Harris, Helen Neighbour, Marie‐Ève Boulay and Paul K. Keith and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Epidemiology and Pediatric Pulmonology.

In The Last Decade

Mena Soliman

28 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mena Soliman Canada 10 291 147 115 48 26 32 355
Stanislaus Ting United States 12 144 0.5× 111 0.8× 78 0.7× 60 1.3× 6 0.2× 21 313
S Ruffoni Italy 8 181 0.6× 168 1.1× 58 0.5× 69 1.4× 4 0.2× 15 276
D. Berra Italy 11 268 0.9× 242 1.6× 126 1.1× 91 1.9× 15 362
Rūta Dubakienė Lithuania 8 69 0.2× 99 0.7× 34 0.3× 32 0.7× 2 0.1× 17 177
J. Garde Garde Spain 11 231 0.8× 161 1.1× 169 1.5× 52 1.1× 25 353
CM Salome Australia 7 314 1.1× 82 0.6× 191 1.7× 12 0.3× 7 433
Giovita Piccillo Italy 5 206 0.7× 115 0.8× 106 0.9× 42 0.9× 1 0.0× 9 253
Jonathan Malka-Rais United States 8 261 0.9× 75 0.5× 231 2.0× 25 0.5× 11 356
R.A. Nathan United States 9 338 1.2× 226 1.5× 201 1.7× 34 0.7× 27 400
Vinciane D’Alpaos Belgium 10 101 0.3× 59 0.4× 89 0.8× 102 2.1× 4 0.2× 12 308

Countries citing papers authored by Mena Soliman

Since Specialization
Citations

This map shows the geographic impact of Mena Soliman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mena Soliman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mena Soliman more than expected).

Fields of papers citing papers by Mena Soliman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mena Soliman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mena Soliman. The network helps show where Mena Soliman may publish in the future.

Co-authorship network of co-authors of Mena Soliman

This figure shows the co-authorship network connecting the top 25 collaborators of Mena Soliman. A scholar is included among the top collaborators of Mena Soliman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mena Soliman. Mena Soliman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bacharier, Leonard B., Jorge Máspero, Nikolaos G. Papadopoulos, et al.. (2025). Dupilumab Plus Medium‐Dose Inhaled Corticosteroid (ICS) Improves Outcomes Compared With Placebo Plus Continued High‐Dose ICS in Children With Uncontrolled Moderate‐to‐Severe Type 2 Asthma. Pediatric Pulmonology. 60(7). e71197–e71197.
3.
Pavord, Ian, Njira Lugogo, Mario Castro, et al.. (2025). Transient early blood eosinophil increases do not affect dupilumab’s long-term efficacy in patients with moderate-to-severe asthma. Journal of Allergy and Clinical Immunology. 157(2). 363–373.
4.
Canonica, Giorgio Walter, J. Christian Virchow, Arnaud Bourdin, et al.. (2025). Real-world comparative effectiveness of biologic therapies in severe asthma: EU-ADVANTAGE. ERJ Open Research. 11(4). 1217–2024.
5.
Mayers, Irvin, Christina Qian, Manisha Talukdar, et al.. (2023). Asthma-related emergency admissions and associated healthcare resource use in Alberta, Canada. BMJ Open Respiratory Research. 10(1). e001934–e001934. 3 indexed citations
6.
Noorduyn, Stephen G., Christina Qian, Karissa Johnston, et al.. (2022). SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada). ERJ Open Research. 8(3). 140–2022. 15 indexed citations
7.
Sadatsafavi, Mohsen, J. Mark FitzGerald, Paul M. O’Byrne, et al.. (2021). The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada. Allergy Asthma and Clinical Immunology. 17(1). 108–108. 9 indexed citations
8.
Johnston, Karissa, Christina Qian, Mena Soliman, Stephen G. Noorduyn, & Erika Penz. (2021). Treatment patterns of patients with chronic obstructive pulmonary disease (COPD) in Ontario, Canada. PA2414–PA2414. 2 indexed citations
9.
Soliman, Mena, et al.. (2020). Usage Patterns of Short-Acting β2-Agonists and Inhaled Corticosteroids in Asthma: A Targeted Literature Review. The Journal of Allergy and Clinical Immunology In Practice. 8(8). 2556–2564.e8. 38 indexed citations
10.
Soliman, Mena, et al.. (2020). <p>Understanding Patient Perspectives on Medication Adherence in Asthma: A Targeted Review of Qualitative Studies</p>. Patient Preference and Adherence. Volume 14. 541–551. 62 indexed citations
11.
Noorduyn, Stephen G., et al.. (2020). SABA overreliance and physician visits in Canada. Epidemiology. 4645–4645. 1 indexed citations
12.
Soliman, Mena, et al.. (2018). Repeatability of nasal allergen challenge results. Annals of Allergy Asthma & Immunology. 120(6). 607–613. 4 indexed citations
13.
Neighbour, Helen, Mena Soliman, Lisa M. Steacy, et al.. (2018). The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): verification of nasal allergen challenge procedures in a study utilizing an investigational immunotherapy for cat allergy. Clinical and Translational Allergy. 8(1). 15–15. 16 indexed citations
14.
Ellis, Anne K., et al.. (2016). Clinical validation of controlled exposure to birch pollen in the Environmental Exposure Unit (EEU). Allergy Asthma and Clinical Immunology. 12(1). 53–53. 15 indexed citations
15.
Soliman, Mena, et al.. (2016). Administering multiple cumulative allergen challenges. Annals of Allergy Asthma & Immunology. 117(3). 326–328. 5 indexed citations
16.
North, Michelle L., Mena Soliman, Terry Walker, Lisa M. Steacy, & Anne K. Ellis. (2015). Controlled Allergen Challenge Facilities and Their Unique Contributions to Allergic Rhinitis Research. Current Allergy and Asthma Reports. 15(4). 11–11. 24 indexed citations
17.
Ellis, Anne K. & Mena Soliman. (2015). Year in review: upper respiratory diseases. Annals of Allergy Asthma & Immunology. 114(3). 168–169. 2 indexed citations
18.
Ellis, Anne K., Mena Soliman, Marie‐Ève Boulay, et al.. (2015). The Allergic Rhinitis – Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies. Allergy Asthma and Clinical Immunology. 11(1). 16–16. 68 indexed citations
19.
Soliman, Mena, et al.. (2014). Nasal allergen challenge studies of allergic rhinitis: a guide for the practicing clinician. Annals of Allergy Asthma & Immunology. 113(3). 250–256. 19 indexed citations
20.
Dunnett, M., et al.. (1997). Carnosine, anserine and taurine contents in individual fibres from the middle gluteal muscle of the camel. Research in Veterinary Science. 62(3). 213–216. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanislaus Ting Breakdown of academic impact, for papers by S Ruffoni Breakdown of academic impact, for papers by D. Berra Breakdown of academic impact, for papers by Rūta Dubakienė Breakdown of academic impact, for papers by J. Garde Garde Breakdown of academic impact, for papers by CM Salome Breakdown of academic impact, for papers by Giovita Piccillo Breakdown of academic impact, for papers by Jonathan Malka-Rais Breakdown of academic impact, for papers by R.A. Nathan Breakdown of academic impact, for papers by Vinciane D’Alpaos
Rankless by CCL
2026